Transform the subject from the input image into appealing claymation character, keep likeness. Handmade plasticine style, ...

Google removes its subscription paywall, allowing free Gemini US users to generate personalized AI artwork using their ...

Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.

Databricks is in talks to raise at $165-175bn, four months after closing at $134bn. CEO Ghodsi has privately signalled an IPO as soon as next year. Discussions are early-stage and the round has not ...

Databricks, a data software company, plans to sell shares to the public at some point, but won’t tap the public markets this year amid a flurry of planned tech IPOs. The company wants to sell shares ...

Agentic AI is moving rapidly from the developer terminal to the corporate world. On Tuesday, OpenAI announced a major update of its agentic AI platform Codex, introducing domain-specific workflows, a ...

Damaged DNA can escape from one human cell and infiltrate another. Like prisoners tunneling out of jail, this DNA travels via tubelike structures between neighboring cells, scientists report May 19 in ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke Koike Supported by By Susan Dominus Why are babies born young? The most ...

Canadians swallow millions of pills every day to treat common health issues like high blood pressure, high cholesterol and Type II diabetes, but scientists are working at the molecular level to turn ...

Databricks has previewed a new open agentic Security Information and Event Management software (SIEM) named Lakewatch that signals its first deliberate step beyond data warehousing into security ...

Three of the biggest names in the artificial intelligence revolution appear on track to launch IPOs in 2026 amid a wave of hype, massive valuations, and for most investors, very little visibility into ...